The work will include developing the study protocol for the TRIUMPH study. Dr. Levitsky will be working with the study team at the ITN by way of weekly calls and working as well as on his own in developing the protocol.
|Effective start/end date||6/1/20 → 1/31/21|
- Benaroya Research Institute at Virginia Mason (FY20ITN371//5UM1AI109565-07)
- National Institute of Allergy and Infectious Diseases (FY20ITN371//5UM1AI109565-07)